See also this year's filing and all EDGAR filings for this company.
PDF Report 0001351288_2021_GW_PHARMACEUTICALS_PLC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001351288')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001351288, GW PHARMACEUTICALS PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 729,530,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,524,000 |
| 2 | PropertyPlantAndEquipmentNet | 143,767,000 |
| 3 | remainder_Assets | 53,690,000 |
| 4 | LiabilitiesCurrent | 159,806,000 |
| 5 | LiabilitiesNoncurrent | 38,615,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 37,531,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 336,043,000 |
| 9 | ResearchAndDevelopmentExpense | 205,396,000 |
| 10 | remainder_Expenses | 4,203,000 |
| 11 | remainder_Revenues | 527,205,000 |
| 12 | remainder_NetIncome | -2,160,000 |
| 13 | remainder_ComprehensiveNetIncome | 15,072,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 939,511,000 |
| 1 | Liabilities | 198,421,000 |
| 2 | Expenses | 583,173,000 |
| 3 | Revenues | 527,205,000 |
| 4 | StockholdersEquity | 741,090,000 |
| 5 | NetIncome | -58,128,000 |
| 6 | ComprehensiveNetIncome | -50,592,000 |
| 7 | BaseVar | 1,132,771,000 |
| 8 | EconomicCapitalRatio | 2.15 |